PET/CT Imaging Patterns in Pyrexia of Unknown Origin (PUO)
[18F]FDG PET/CT demonstrates high diagnostic yield in patients with PUO, with a sensitivity of 84% and specificity of 62%, capable of identifying the underlying cause in approximately 56% of cases. 1, 2
Key Imaging Patterns in PUO
Common Causes and Their Imaging Patterns
Infections (most common cause):
- Focal increased [18F]FDG uptake in abscesses (including splenic)
- Linear or focal uptake in endocarditis (11% of PUO cases) 2
- Increased uptake in osteomyelitis showing bone involvement
- Diffuse or focal uptake in infected prosthetic devices
Non-infectious inflammatory diseases:
Malignancies:
- Focal or multifocal intense uptake in lymphoma (especially Hodgkin's and aggressive non-Hodgkin's)
- Focal uptake in solid tumors (colorectal cancer, sarcomas)
- Diffuse bone marrow uptake in hematologic malignancies
Diagnostic Performance
PET/CT demonstrates excellent performance in PUO evaluation:
- Sensitivity: 84% (79-89%)
- Specificity: 62% (49-75%)
- Diagnostic yield: 56% (50-61%)
- Diagnostic accuracy: 76%
- Helpfulness in clinical management: 61% 1
The high negative predictive value (80.9-100%) is particularly valuable, as a negative scan essentially rules out focal pathology as the cause of fever 2, 3.
Technical Considerations
Optimal Timing and Protocol
- Perform [18F]FDG PET/CT within 3 days of initiating glucocorticoid therapy to avoid false negatives 1
- Consider myocardial suppression preparation when cardiac etiology is suspected 1
- Early implementation in the diagnostic workup improves outcomes by allowing timelier diagnosis 2
Interpretation Pitfalls
False positives can occur due to:
- Recent surgical procedures
- Foreign body reactions
- Inadequate suppression of physiological myocardial FDG uptake
- Normal physiological uptake in certain organs (brain, heart, urinary tract) 2
False negatives may occur with:
- Prior extended antibiotic therapy (suppresses inflammatory activity)
- Small or mobile lesions
- Systemic diseases without focal manifestations 2
Clinical Applications
PET/CT is particularly valuable when:
- Conventional imaging is negative or inconclusive
- Initial basic investigations have failed to identify the cause
- Inflammatory markers (CRP, ESR) are elevated 1, 2
Important caveat: PET/CT has insufficient evidence for evaluation of PUO with normal inflammatory markers 1.
Impact on Patient Management
The results of [18F]FDG PET/CT can:
- Guide further investigations and biopsy
- Direct specific treatment when the cause is established
- Lead to treatment modifications in approximately 53% of cases 2
- Predict favorable prognosis through spontaneous resolution when negative 1
Emerging Technologies
PET/MRI shows potential but currently has insufficient data to support routine use in PUO evaluation 1, 2.